CH Biotech R&D Co (TPE:6534) Moat Score: 0/10 (As of Jul. 07, 2026)


TPE:6534 CH Biotech R&D Co Ltd TPE:6534
84 GF Score
Price NT$90.20
GF Value NT$100.55
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is CH Biotech R&D Co Moat Score?

CH Biotech R&D Co has the Moat Score of 0, which implies that the company might have No Moat - No discernible moat.

CH Biotech R&D Co has

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes CH Biotech R&D Co might have No Moat - No discernible moat.

CH Biotech R&D Co  (TPE:6534) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

CH Biotech R&D Co Moat Score Related Terms

TPE:6534
84GF Score
CH Biotech R&D Co Ltd TPE:6534
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is CH Biotech R&D Co (TPE:6534) Overvalued in 2026?

Based on GuruFocus' analysis, CH Biotech R&D Co stock appears to be undervalued. The current stock price of NT$90.20 is trading 10.3% below its estimated GF Value™ of NT$100.55. GuruFocus considers CH Biotech R&D Co to be Modestly Undervalued.

Key valuation signals for TPE:6534:

  • Moat Score: 0
  • GF Value™: NT$100.55 vs. price of NT$90.20 (10.3% below fair value)
  • GF Score™: 84/100 with 1 warning sign

No single metric tells the full story. See the TPE:6534 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

CH Biotech R&D Co Business Description

Address No. 89, Wenxian Road, Nantou County, Nantou City, TWN, 540001
CH Biotech R&D Co Ltd is a Taiwan-based company engaged in the manufacture and sales of fertilizer, as well as providing biotechnology services. It is engaged in the research, development, manufacturing, and sales of proprietary plant growth regulators and specialty micronutrient fertilizers. It offers NutriSync 3D plant growers in the form of boron and molybdenum, NutriSync D liquid formulation for dicot crops, CHB-HS for reducing carbon emissions in crop production, CHB-BB2, fruit quality enhancers, and other related products. The company has one reportable segment, Agricultural Biotechnology. Geographically, it derives maximum revenue from the United States, and the rest from other countries.
84GF Score

Get the complete analysis for TPE:6534

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$90.20
Price
NT$100.55
GF Value